rb 101 has been researched along with pbc 264 in 1 studies
Studies (rb 101) | Trials (rb 101) | Recent Studies (post-2010) (rb 101) | Studies (pbc 264) | Trials (pbc 264) | Recent Studies (post-2010) (pbc 264) |
---|---|---|---|---|---|
57 | 0 | 2 | 7 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Durieux, C; FourniƩ-Zaluski, MC; Roques, BP; Ruiz-Gayo, M | 1 |
1 other study(ies) available for rb 101 and pbc 264
Article | Year |
---|---|
Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Topics: Analgesics; Analgesics, Opioid; Animals; Cholecystokinin; Dipeptides; Disulfides; Dose-Response Relationship, Drug; Enkephalins; Male; Mice; Narcotic Antagonists; Peptide Fragments; Phenylalanine; Prodrugs; Receptors, Cholecystokinin; Receptors, Opioid | 1992 |